Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German…
By C. Rödel, T. Liersch, H. Becker, R. Fietkau, W. Hohenberger, Torsten Hothorn, U. Graeven, D. Arnold, M. Lang-Welzenbach, H. Raab and 12 more. The Lancet Oncology, 2012
628 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/5fc88f482d28f7c8c2b12d9ac103006b34e614d0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges (2019, methodology): “Meng et al [173] Retrospective, single center study 54 + 54 485 (Shape, Intensity Texture) log-rank test, LASSO Cox regression MRI Prognosis”
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer (2012, background): “In randomized controlled trials into the efficacy of adding OX to pyrimidine fluoride as a combination chemotherapy in the preoperative chemoradiotherapy, OX increased harmful phenomena in three tests, but demonstrated no efficacy in regard to pCR ratio, localized control ratio and survival [120, 12”
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. (2012, neutral): “5% was shown [64].”